Kevin Read,
Head-DMPK
Kevin Read’s background is in drug metabolism and pharmacokinetics, with extensive experience of early phase drug discovery, lead optimisation, project leadership and preclinical development gained from over 25 years in the pharmaceutical industry and in the Drug Discovery Unit at the University of Dundee (DDU). At GlaxoSmithKline, Kevin achieved a considerable track record of success in drug discovery, playing a significant part in 7 compounds entering pre-clinical development, 4 of which entered clinical trials. Kevin then moved to Dundee in 2008, joining the management team of the DDU and to fully integrate the DDU as an early drug discovery engine for neglected tropical diseases. He co-led the malaria project team that delivered the first pre-clinical development candidate for the DDU.
|
|
|
